OPT 4.88% 43.0¢ opthea limited

Ann: Opthea Completes Enrollment in Phase 3 Clinical Program, page-22

  1. 39 Posts.
    lightbulb Created with Sketch. 10
    Strange share price action. I have bought more at this level. I remain confident in longer term value.

    An interesting question is how much more cash will OPT have to obtain to complete trials. Are there any views on this out there?
 
watchlist Created with Sketch. Add OPT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.